HuagongsheHuagongshe Chemistry Print Report · For research reference only
(6-Bromoisochroman-1-yl)acetic acid → 1-(4-Chlorophenyl)-4-[2-(6-bromoisochroman-1-yl)ethyl]piperazine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (6-Bromoisochroman-1-yl)acetic acid | HCID 10540012 | — |
| Reactant | 1-[2-(Isochroman-1-yl)ethyl]-4-(2-methoxyphenyl)piperazine dihydrochloride monohydrate | HCID 23288951 | — |
| Reactant | 1-(4-Chlorophenyl)-4-[2-(6-bromoisochroman-1-yl)]acetyl piperazine | HCID 53966005 | — |
| Product | 1-(4-Chlorophenyl)-4-[2-(6-bromoisochroman-1-yl)ethyl]piperazine | HCID 23288875 | — |
Reaction Steps
(6-Bromoisochroman-1-yl)acetic acid (EXAMPLE 22, LXVIII) is coupled with 4-chlorophenylpiperazine (XI) and the resulting amide, 1-(4-chlorophenyl)-4-[2-(6-bromoisochroman-1-yl)]acetyl piperazine (LXIII, 1.39 mmol) is reduced according to the general procedure of EXAMPLE 50 and making non-critical variations, to give the title compound, mp 94-96°; IR (mull) 1500, 1483, 1448, 1248, 1242, 1152, 1144, 1113, 1102, 815 cm-1 ; NMR (300 MHz, CDCl3) 7.32-7.26, 7.19, 6.97, 6.83, 4.78, 4.14-4.07, 3.78-3.69, 3.16, 3.00-2.90, 2.7-2.48, 2.15-1.90; CMR (75 MHz, CDCl3) 149.6, 137.1, 136.0, 131.4, 129.1, 128.7, 126.3, 124.6, 120.0, 116.9, 74.0, 62.6, 54.3, 53.3, 53.0, 48.9, 33.0 and 28.6 δ.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06133446 |
| Source dataset | uspto-grants-2000_10 |
| ORD ID | ord-f3d7eda628e943788e4984882503b16a |
| Source note | uspto-grants-2000_10 |